HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients

scientific article (publication date: 12 May 2011)

HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2010-10-316083
P932PMC publication ID3109545
P698PubMed publication ID21389320
P5875ResearchGate publication ID50351370

P50authorLawrence CoreyQ6503944
Michael BoeckhQ56072917
Meei-Li HuangQ61713476
Wendy LeisenringQ75026076
Danielle M ZerrQ100739238
P2093author name stringJesse R Fann
Colleen Delaney
Hu Xie
David Breiger
Amanda L Adler
P2860cites workHigh levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsQ58473705
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancersQ73427004
Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patientsQ80141489
The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurementQ28203897
Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imagingQ33375328
The Delirium Rating Scale. Its use in consultation-liaison researchQ33643269
Identifying meaningful intra-individual change standards for health-related quality of life measuresQ33916167
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samplesQ33960980
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesQ34583041
Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplantQ35801726
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantationQ36095851
Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantationQ36727466
1994 Consensus Conference on Acute GVHD GradingQ39513397
Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients.Q40613007
Human herpesvirus 6 limbic encephalitis after stem cell transplantationQ43798251
Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipientsQ43843926
Delirium in patients undergoing hematopoietic stem cell transplantationQ44197109
Impact of human herpesvirus-6 after haematopoietic stem cell transplantationQ44872903
The delirium rating scale in children and adolescentsQ46604849
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.Q48110777
Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluidQ48318086
Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantationQ48566891
The Children's Orientation and Amnesia Test: relationship to severity of acute head injury and to recovery of memoryQ48864604
Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation.Q50905386
A symptom rating scale for delirium.Q52071753
Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.Q53577416
Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.Q53633777
Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.Q53646005
P433issue19
P407language of work or nameEnglishQ1860
P921main subjectdeliriumQ160796
cell biologyQ7141
P304page(s)5243-9
P577publication date2011-05-12
P1433published inBloodQ885070
P1476titleHHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients
P478volume117

Reverse relations

cites work (P2860)
Q34273968Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.
Q38116092Biomarkers of delirium as a clue to diagnosis and pathogenesis of Wernicke-Korsakoff syndrome
Q60921241Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults
Q37952634Chromosomally integrated human herpesvirus 6: questions and answers
Q37982856Chromosomally integrated human herpesvirus-6 in transplant recipients
Q59356776Comparison of HHV-6 DNA detection in plasma and whole blood in allogeneic hematopoietic stem cell transplant recipients: frequent false-positive results for active HHV-6 infection using whole blood samples
Q54252789Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.
Q37276889Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Q35752239Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults
Q36834718Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR.
Q40185839Development of real-time RT-PCR assays for detection of three classes of HHV-6A gene transcripts.
Q30883059Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation
Q27345284Early developmental outcomes of children with congenital HHV-6 infection
Q33559473Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation
Q84507133Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis
Q33897804Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin
Q92993210Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
Q38045704HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis
Q41073087HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Q28727925HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation
Q27010284Human Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell Transplantation
Q43971471Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study
Q34195389Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation.
Q41715322Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation
Q35801310Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation
Q38444117Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.
Q48178536Human herpesvirus-6 encephalitis following chemotherapy induction for acute myelogenous leukemia
Q41021152Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation
Q35879617Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR.
Q26827409Immune response to HHV-6 and implications for immunotherapy
Q37006823Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation
Q35482603Laboratory and clinical aspects of human herpesvirus 6 infections
Q92111619Long-term Outcomes of Patients With Human Herpesvirus 6 Encephalitis
Q38002109Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients
Q40264216New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib
Q37189313Persistent human herpesvirus-6 infection in patients with an inherited form of the virus
Q91345168Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation
Q37954124Psychosocial care in cancer
Q34537814Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Q38256992Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials
Q44994852Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation
Q54296983Specific CD8⁺ T cells recognize human herpesvirus 6B.
Q36236659TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes

Search more.